Showing results (301-310 of 358) with videos related to

Sort By:
Pageof 36
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Rapidly fatal pneumonitis from immunotherapy and concurrent SARS-CoV-2 infection in a patient with newly diagnosed lung cancerChristine M Lovly, Kelli L Boyd, Paula I Gonzalez-Ericsson, et al.
Research Square|May 20, 2024
Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer ImmunotherapyJohn Wilson, Blaise Kimmel, Karan Arora, et al.
Journal for Immunotherapy of Cancer|March 18, 2025
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancerJulio C Tinoco, Harmony I Saunders, Lauryn Rose Werner, et al.
JCI Insight|July 8, 2020
MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBCDerek A Franklin, Joe T Sharick, Paula I Ericsson-Gonzalez, et al.
Genome Medicine|May 26, 2019
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq dataFrancesca Finotello, Clemens Mayer, Christina Plattner, et al.
The Oncologist|May 7, 2014
Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panelDouglas B Johnson, Kimberly H Dahlman, Jared Knol, et al.
Genome Medicine|July 31, 2019
Correction to: Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq dataFrancesca Finotello, Clemens Mayer, Christina Plattner, et al.
Cell Metabolism|October 6, 2017
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative PhosphorylationKyung-Min Lee, Jennifer M Giltnane, Justin M Balko, et al.
Nature Medicine|June 12, 2012
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistanceJustin M Balko, Rebecca S Cook, David B Vaught, et al.
Science Translational Medicine|April 22, 2026
Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancerXiaopeng Sun, Andres A Ocampo, Ann Hanna, et al.
Pageof 36